Expand CORT Menu
CORT MENU

CORT Latest Press Releases

-- March 13, 2026 --

Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC PRNewswire 9:51 PM
DEADLINE ALERT for PYPL, SMR, CORT, NAVN: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions Globe Newswire 1:43 PM
CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss Globe Newswire 11:16 AM
CORT Shareholder Alert: Corcept Therapeutics Incorporated Securities Class Action Lawsuit Investors With Losses May Join - The Gross Law Firm Globe Newswire 9:00 AM

-- March 12, 2026 --

ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class Action - CORT Newsfile 5:42 PM

-- March 11, 2026 --

ROSEN, A LEADING NATIONAL FIRM, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class Action - CORT Globe Newswire 8:34 PM
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class Action - CORT Newsfile 5:35 PM
Corcept Therapeutics Shareholders Are Encouraged to Contact Johnson Fistel for More Information About Potentially Recovering Their Losses Globe Newswire 4:48 PM
CORT LAWSUIT ALERT: Levi & Korsinsky Notifies Corcept Therapeutics Incorporated Investors of a Class Action Lawsuit and Upcoming Deadline PRNewswire 9:00 AM

-- March 10, 2026 --

Bragar Eagel & Squire, P.C. Urges Navan and Corcept Investors with Large Losses to Contact the Firm Before the Upcoming Lead Plaintiff Deadlines Globe Newswire 7:04 PM
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Corcept Therapeutics Incorporated (CORT) Investors - Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm Globe Newswire 6:17 PM
REMINDER: Corcept Therapeutics Incorporated Investors With Significant Losses Must Act By April 21, 2026 Business Wire 6:00 PM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines - CORT Globe Newswire 4:04 PM
Corcept Therapeutics (CORT) Litigation: Hagens Berman Alerts Corcept (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline PRNewswire 3:57 PM
Important Notice to Long-Term Shareholders of Boston Scientific Corporation (NYSE: BSX): Corcept Therapeutics, Inc. (NASDAQ: CORT); Nektar Therapeutics (NASDAQ: NKTR): and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf Globe Newswire 9:08 AM

-- March 9, 2026 --

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class Action - CORT Newsfile 11:02 PM
Contact Levi & Korsinsky by April 21, 2026 Deadline to Join Class Action Against Corcept Therapeutics Incorporated(CORT) Globe Newswire 4:00 PM
Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline Globe Newswire 12:01 PM
Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PRNewswire 12:00 PM

-- March 7, 2026 --

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class Action - CORT Newsfile 10:23 PM

-- March 6, 2026 --

Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT PRNewswire 9:52 PM
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class Action - CORT Newsfile 6:03 PM
Class Action Filed Against Corcept Therapeutics Incorporated (CORT) Seeking Recovery for Investors - Contact The Gross Law Firm Globe Newswire 4:00 PM
DEADLINE ALERT for PYPL, SMR, CORT, NAVN: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions Globe Newswire 12:00 PM

-- March 5, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines - CORT PRNewswire 4:59 PM
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class Action - CORT Globe Newswire 4:27 PM
Deadline Alert: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit Globe Newswire 12:00 PM
Important Notice to Long-Term Shareholders of Corcept Therapeutics, Inc. (NASDAQ: CORT); Kyndryl Holdings (NYSE: KD); Molina Healthcare, Inc. (NYSE: MOH); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf Globe Newswire 9:15 AM

-- March 4, 2026 --

ROSEN, A TOP RANKED LAW FIRM, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class Action - CORT Newsfile 7:14 PM
Law Offices of Frank R. Cruz Encourages Corcept Therapeutics Incorporated (CORT) Shareholders To Inquire About Securities Fraud Class Action Business Wire 12:06 PM
Lost Money on Corcept Therapeutics Incorporated(CORT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky PRNewswire 9:00 AM

-- March 3, 2026 --

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class Action - CORT Newsfile 4:09 PM
Important Notice to Long-Term Shareholders of Corcept Therapeutics, Inc. (NASDAQ: CORT); Integer Holdings Corp. (NYSE: ITGR); Kyndryl Holdings (NYSE: KD); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your Behalf Globe Newswire 2:47 PM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines - CORT Globe Newswire 2:02 PM
Deadline Alert: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged to Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit Business Wire 12:00 PM
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm Globe Newswire 10:02 AM
Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline PRNewswire 9:08 AM
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 21, 2026 in Corcept Therapeutics Incorporated Lawsuit - CORT PRNewswire 9:00 AM
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Corcept Therapeutics Incorporated (CORT) Globe Newswire 8:23 AM

-- March 2, 2026 --

Shareholders who lost money in shares of Corcept Therapeutics (NASDAQ: CORT) should contact Wolf Haldenstein immediately Globe Newswire 4:51 PM
Class Action Filed Against Corcept Therapeutics Incorporated (CORT) Seeking Recovery for Investors - Contact Levi & Korsinsky Globe Newswire 4:00 PM
ROSEN, A LEADING AND RANKED FIRM, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class Action - CORT Globe Newswire 3:42 PM
Deadline Approaching: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith Business Wire 12:00 PM
Important Notice to Long-Term Shareholders of Corcept Therapeutics, Inc. (NASDAQ: CORT); Five9, Inc. (NASDAQ: FIVN); Integer Holdings Corp. (NYSE: ITGR); and Kyndryl Holdings (NYSE: KD): Grabar Law Office Investigates Claims on Your Behalf Globe Newswire 9:47 AM

-- March 1, 2026 --

ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class Action - CORT Newsfile 5:30 PM

-- February 27, 2026 --

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class Action - CORT Globe Newswire 5:30 PM
Corcept Therapeutics (CORT) Litigation: Hagens Berman Alerts CORT Investors to Securities Class Action and April 21 Lead Plaintiff Deadline Globe Newswire 1:58 PM
DEADLINE ALERT for KD, PYPL, SMR, and CORT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders Globe Newswire 12:06 PM
Corcept Therapeutics Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CORT PRNewswire 2:54 AM

-- February 26, 2026 --

Portnoy Law Firm Announces Class Action on Behalf of Corcept Therapeutics Incorporated Investors Globe Newswire 10:40 PM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines - CORT PRNewswire 3:17 PM
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Corcept Therapeutics Incorporated (CORT) Shareholders To Inquire About Securities Fraud Class Action Business Wire 12:00 PM
CORT Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Corcept Therapeutics Inc. Class Action Lawsuit Globe Newswire 9:00 AM
CORCEPT THERAPEUTICS INCORPORATED (CORT) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Corcept Therapeutics Incorporated Investors of Upcoming Deadline Globe Newswire 8:34 AM

-- February 25, 2026 --

Law Offices of Howard G. Smith Encourages Corcept Therapeutics Incorporated (CORT) Shareholders To Inquire About Securities Fraud Class Action Business Wire 5:32 PM
ROSEN, A LEADING LAW FIRM, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class Action - CORT Newsfile 5:15 PM
INVESTOR DEADLINE: Corcept Therapeutics Incorporated (CORT) Investors with Substantial Losses Have Opportunity to Lead the Corcept Class Action Lawsuit - RGRD Law Globe Newswire 4:10 PM
Corcept Therapeutics Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CORT Business Wire 7:15 AM

-- February 24, 2026 --

CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm Business Wire 10:03 PM
CORT Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Corcept Therapeutics Inc. PRNewswire 5:09 PM
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class Action - CORT Globe Newswire 4:08 PM
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2025 Audited Financial Results, Provides Corporate Update Business Wire 4:05 PM
INVESTOR DEADLINE: Corcept Therapeutics Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces Business Wire 12:05 PM
Bronstein, Gewirtz & Grossman LLC Urges Corcept Therapeutics Incorporated Investors to Act: Class Action Filed Alleging Investor Harm Globe Newswire 12:00 PM
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Corcept Therapeutics Incorporated (CORT) Globe Newswire 11:02 AM
Corcept Therapeutics (CORT) Litigation: Hagens Berman Alerts Corcept (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline PRNewswire 8:34 AM
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Corcept Therapeutics Incorporated (CORT) Globe Newswire 8:22 AM

-- February 23, 2026 --

CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit PRNewswire 7:25 PM
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC Business Wire 7:18 PM
CORCEPT CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Corcept Therapeutics Incorporated and Encourages Investors to Contact the Firm Globe Newswire 6:54 PM
INVESTOR ALERT: Securities Class Action Filed Against Corcept Therapeutics Incorporated - Investors Encouraged to Contact Kirby McInerney LLP Business Wire 6:00 PM
Rosen Law Firm Urges Corcept Therapeutics Incorporated (NASDAQ: CORT) Stockholders to Contact the Firm for Information About Their Rights Business Wire 4:00 PM
CORCEPT THERAPEUTICS INCORPORATED (CORT) INVESTOR ALERT Investors With Large Losses in Corcept Therapeutics Incorporated Should Contact Bernstein Liebhard LLP To Discuss Their Rights Globe Newswire 2:47 PM
Corcept Therapeutics (CORT) Litigation: Hagens Berman Alerts Corcept (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline Globe Newswire 2:22 PM
Corcept Therapeutics Shareholders Are Encouraged to Contact Johnson Fistel for More Information About Potentially Recovering Their Losses Globe Newswire 12:21 PM
INVESTOR DEADLINE: Corcept Therapeutics Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit PRNewswire 9:12 AM

-- February 20, 2026 --

INVESTOR ALERT: Corcept Therapeutics Incorporated Investors with Substantial Losses Have Opportunity to Lead the Corcept Class Action Lawsuit - RGRD Law Globe Newswire 8:28 PM
Investor Alert: Robbins LLP Informs Investors of the Corcept Therapeutics Inc. Class Action Lawsuit Business Wire 8:13 PM

-- February 19, 2026 --

Corcept Provides Update on Patent Dispute with Teva Pharmaceuticals Business Wire 4:00 PM

-- February 17, 2026 --

Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2025 Financial Results, Provide Corporate Update and Host Conference Call Business Wire 4:05 PM

-- February 12, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT PRNewswire 6:56 PM

-- February 9, 2026 --

CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm Globe Newswire 10:58 AM
CORT INVESTIGATION ALERT: Investigation Launched into Corcept Therapeutics (CORT), Hagens Berman Encourages Investors to Contact Firm PRNewswire 8:12 AM
Corcept Therapeutics Incorporated Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights - CORT PRNewswire 4:54 AM
CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm PRNewswire 3:38 AM

-- February 5, 2026 --

CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm PRNewswire 5:21 AM
Corcept Therapeutics Incorporated Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights - CORT PRNewswire 4:48 AM

-- February 4, 2026 --

CORCEPT INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Encourages Corcept Therapeutics Investors to Contact the Firm Regarding Ongoing Investigation Globe Newswire 5:10 PM
Securities Fraud Investigation Into Corcept Therapeutics Incorporated (CORT) Announced - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Business Wire 2:58 PM

-- February 3, 2026 --

Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigation Business Wire 4:00 PM
Securities Fraud Investigation Into Corcept Therapeutics Incorporated (CORT) Announced - Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz Business Wire 3:26 PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Corcept Therapeutics Incorporated - CORT Globe Newswire 2:02 PM

-- February 2, 2026 --

CORT INVESTIGATION ALERT: Investigation Launched into Corcept Therapeutics (CORT), Hagens Berman Encourages Investors to Contact Firm PRNewswire 5:46 PM
Corcept Therapeutics Incorporated Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights - CORT PRNewswire 4:42 AM
CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm PRNewswire 4:41 AM

-- January 30, 2026 --

Hagens Berman Investigating Corcept Therapeutics (CORT): Shares Fall After Report That FDA Warned Against Relacorilant Drug Application Filing Business Wire 8:32 PM
Corcept Therapeutics (CORT) Shares Fall Again Amid Report FDA Warned Several Times Not to Submit Relacorilant Drug Application - Hagens Berman Globe Newswire 3:28 PM
Berman Tabacco Announces Investigation of Corcept Therapeutics Incorporated (NASDAQ: CORT) Concerning FDA New Drug Application Globe Newswire 2:20 PM
Rosen Law Firm Encourages Corcept Therapeutics Incorporated Investors to Inquire About Securities Class Action Investigation - CORT Business Wire 12:30 PM
CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated Globe Newswire 11:27 AM
Corcept Therapeutics Investigated for Securities Fraud Following Report of FDA Warnings; Shareholders Should Contact Block & Leviton To Recover Losses Globe Newswire 10:13 AM

-- January 29, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT PRNewswire 10:00 AM
CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm PRNewswire 4:30 AM
Corcept Therapeutics Incorporated Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights - CORT PRNewswire 4:29 AM

-- January 28, 2026 --

CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm Globe Newswire 10:00 AM

-- January 27, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT Globe Newswire 1:24 PM

-- January 22, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT PRNewswire 10:00 AM
Overall Survival Primary Endpoint Met in Corcept's Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer Business Wire 8:00 AM

-- January 21, 2026 --

CORT INVESTIGATION ALERT: Investigation Launched into Corcept Therapeutics (CORT), Hagens Berman Encourages Investors to Contact Firm PRNewswire 6:36 PM

-- January 20, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT Globe Newswire 1:27 PM

-- January 15, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT PRNewswire 10:00 AM
CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm PRNewswire 1:29 AM

-- January 14, 2026 --

Corcept Therapeutics Incorporated Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights - CORT Business Wire 9:52 PM
INVESTOR ALERT: Investigation of Corcept Therapeutics Incorporated (CORT) by Holzer & Holzer, LLC Globe Newswire 3:39 PM
Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% - Hagens Berman PRNewswire 11:56 AM

-- January 13, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT Globe Newswire 3:56 PM

-- January 12, 2026 --

CORT Investor ALERT: Corcept Therapeutics Inc. Investigated for Securities Fraud; Investors Should Contact Block & Leviton To Potentially Recover Losses Globe Newswire 11:54 AM

-- January 9, 2026 --

Scott+Scott Attorneys at Law LLP Reminds Investors of Its Investigation Into Corcept Therapeutics Incorporated (NASDAQ: CORT) Business Wire 10:00 AM

-- January 8, 2026 --

CORCEPT ALERT: Bragar Eagel & Squire, P.C. is Investigating Corcept Therapeutics Incorporated on Behalf of Corcept Stockholders and Encourages Investors to Contact the Firm Globe Newswire 4:26 PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT PRNewswire 10:00 AM
Scott+Scott Attorneys at Law LLP Reminds Investors of Its Investigation Into Corcept Therapeutics Incorporated (NASDAQ: CORT) Globe Newswire 10:00 AM

-- January 7, 2026 --

CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm Business Wire 8:03 PM
Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% - Hagens Berman Globe Newswire 5:58 PM

-- January 6, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT Globe Newswire 12:53 PM
Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% - Hagens Berman PRNewswire 12:01 PM

-- December 31, 2025 --

Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism Business Wire 8:00 AM

-- November 4, 2025 --

Corcept Therapeutics Announces Third Quarter Financial Results, Oncology Development Programs and Provides Corporate Update Business Wire 4:05 PM

-- October 28, 2025 --

Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call Business Wire 4:05 PM

-- October 19, 2025 --

Corcept Presents ESMO 2025 Late-Breaker: Relacorilant Demonstrates Benefit in Patients with Platinum-Resistant Ovarian Cancer with Prior PARP Inhibitor Treatment Business Wire 5:15 AM

-- October 14, 2025 --

Corcept Submits Marketing Authorization Application to European Medicines Agency for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer Business Wire 8:00 AM
Market Data Delayed 15 Minutes